Introduction {#S0001}
============

The circadian clock and the cell cycle are two fundamental, highly dynamic, and evolutionary well conserved biological oscillators that employ cyclic gene expression and protein degradation to impose diurnal rhythmicity on behavior, physiology and metabolism, and to drive cell division, respectively.

The mammalian circadian clock consists of a light-entrainable central clock located in the hypothalamic suprachiasmatic nucleus (SCN) of the brain, and peripheral clocks situated in the individual cells of almost all other tissues \[[1](#CIT0001)\]. At the molecular level, the circadian clock is based on intertwined positive and negative transcriptional-translational feedback loops \[[2](#CIT0002)\]. In short, the positive elements of the circadian clock, encoded by the *Brain* and *Muscle Arnt-like protein-1 (Bmal1*) and the *Clock* genes, form a heterodimer that activates transcription of E-box promoter element containing genes, including the core clock genes *Period* (*Per1* and *Per2), Cryptochrome (Cry1 and Cry2*), and nuclear hormone receptor *Rev-Erbα*. Once formed, PER and CRY proteins heterodimerize and translocate to the nucleus where they inhibit CLOCK/BMAL1-mediated transcription of E-box genes, including their own \[[2](#CIT0002)\]. Post-translational modification events, including phosphorylation and ubiquitination, target the PER and CRY proteins for degradation by the 26S proteasome complex, which in turn allows reactivation of CLOCK/BMAL1-mediated transcription and initiation of a new circadian cycle \[[3](#CIT0003),[4](#CIT0004)\]. In addition, CLOCK/BMAL1-driven cyclic expression of the *Rev-Erbα* gene (encoding an inhibitor of ROR-driven *Bmal1* expression) causes *Bmal1* expression to oscillate, which confers robustness to the circadian core oscillator. BMAL1 and CLOCK are also responsible for the cyclic transcription of E-box-containing clock-controlled genes (CCG) that couple the circadian oscillator to a wide variety of physiological pathways.

Similar to the circadian clock, the cell cycle behaves as an oscillator in which cyclic expression of key cell cycle molecules (i.e. cyclins) regulates cell cycle progression in a sequential and unidirectional manner \[[5](#CIT0005),[6](#CIT0006)\]. Cyclins are produced at specific stages of the cell cycle and associate with their respective constitutively expressed Cyclin-Dependent Kinase (CDK) partner. The kinase activity of the cyclin-CDK complexes triggers various events at specific times during the cell cycle. In short, mitogenic signals prompt the expression of Cyclin D, which binds to CDK4 and CDK6 and irreversibly drives the cell through G1 phase and prepares it for replication. The underlying signalling cascade includes activation of the *Ccne1* and *Ccna2* cyclin genes \[[7](#CIT0007)\]. Cyclin E protein levels peak at late G1, resulting in the formation of Cyclin E/CDK2 complexes that initiate G1/S transition and subsequent DNA replication \[[8](#CIT0008),[9](#CIT0009)\]. Cyclin A2 starts to appear during S phase and, along with its catalytic subunit CDK2, is essential for DNA replication and S phase progression \[[10](#CIT0010)--[12](#CIT0012)\]. Ablation of Cyclin A2 in cultured cells blocks DNA synthesis and delays S phase progression \[[13](#CIT0013),[14](#CIT0014)\]. Mitotic entry is triggered by Cyclin B1/CDK1 \[[15](#CIT0015)\]. Transcription of the Cyclin B1 gene *CcnB1* starts in S phase with Cyclin B1 protein levels and Cyclin B1/CDK1 complex formation peaking at late G2 \[[16](#CIT0016),[17](#CIT0017)\]. However, Cyclin B1/CDK1 complexes are initially kept in an inactive state by WEE1 and MYT1 kinase-mediated phosphorylation of specific CDK1 residues to avoid premature mitosis \[[17](#CIT0017)--[19](#CIT0019)\]. Once protein levels are sufficiently high, Cyclin B1 triggers the de-phosphorylation of CDK1, thereby activating its own (i.e. Cyclin B1/CDK1) complex and promotes entry into mitosis \[[16](#CIT0016)\]. In conclusion, oscillations in the amount and activity of the various Cyclin/CDK complexes are crucial for cell cycle progression.

Multiple studies have provided evidence for a strong connection between the circadian clock and cell cycle in proliferating cells. Bjarnason and coworkers have shown circadian variation in the abundance of cell cycle proteins in human oral mucosa \[[20](#CIT0020)\]. Moreover, expression of clock genes in human oral mucosa and skin was associated with specific cell cycle phases. Notably, peak expression of the Cyclin B1 gene *Cnnb1* coincides with that of the *Bmal1* clock gene, while *Per1* transcription coincides with the peak of *p53* mRNA levels in late G1 \[[21](#CIT0021)\]. Studies addressing the molecular link between the circadian and cell cycle oscillator have shown that the circadian clock can affect the cell cycle at different levels. For instance, expression of the G2/M inhibitor WEE1 is under circadian control via CLOCK/BMAL1 responsive E-box elements in the *Wee1* gene promoter \[[22](#CIT0022)\]. Likewise, G1 to S transition has been reported to be under circadian control through CLOCK/BMAL1-mediated cyclic transcription of the cell cycle inhibitor gene *p21WAF1/CIP1* \[[23](#CIT0023)\]. Furthermore, the multifunctional nuclear protein NONO was found to bind to the promoter of the p16-Ink4A cell cycle checkpoint gene and drive circadian expression in a PER-dependent manner \[[24](#CIT0024)\]. Oppositely, the cell cycle regulator protein CDK1 has been suggested to control the circadian clock through phosphorylation of REV-ERBα, which targets the latter protein for FBXW7α-mediated degradation \[[25](#CIT0025)\].

Besides those molecular links, initial studies with NIH3T3 cells containing a fluorescent clock reporter that allows time lapse imaging of the circadian clock in individual proliferating cells revealed that mitosis occurred at specific time windows, suggesting that cell division is gated by the circadian clock \[[26](#CIT0026)\]. Recently, we and others used aforementioned NIH3T3 cells to address the dynamic coupling between the clock and cell cycle in more detail by simultaneous single-cell time lapse imaging of circadian clock performance and cell cycle progression, the latter visualized through mitotic events \[[27](#CIT0027)\] or fluorescent cell cycle reporters \[[28](#CIT0028)\]. Interestingly, in the absence of external resetting cues, the cell cycle and circadian clock were shown to be phase locked in a 1:1 ratio, with the clock reporter reproducibly peaking 5 h after mitosis \[[27](#CIT0027),[28](#CIT0028)\]. Notably, the length of the circadian cycle in proliferating cells adjusted to that of the cell cycle. On the other hand, synchronization of the circadian clock by physiological cues (such as dexamethasone) causes clustering of cell divisions, indicating that the cell cycle is synchronized via the circadian clock and that, accordingly, the coupling between these two oscillators is bidirectional \[[28](#CIT0028)\]. The molecular nature of the coupling of the circadian clock to the cell cycle nevertheless remains to be determined. Mathematical models for the circadian clock \[[29](#CIT0029),[30](#CIT0030)\] and the cell cycle \[[6](#CIT0006),[31](#CIT0031)\] have been integrated into a comprehensive computational model \[[32](#CIT0032)\] that enables the in silico analysis of the connection between the circadian clock and the cell cycle based on the molecular information provided in literature. This approach has provided new insight into the interaction of these oscillating systems and the conditions under which the cell cycle can be entrained by the circadian clock as a function of both the strength of coupling to the circadian clock and the duration of the cell cycle prior to such coupling \[[32](#CIT0032)\].

Although our knowledge on the coupling of the circadian clock and cell cycle is steadily increasing, relatively little is known on how genetic clock defects affect the interaction between these two oscillatory machineries. In the current study, we used our NIH3T3^3C^ mouse fibroblast line with fluorescent reporter genes for the circadian clock and cell cycle phase \[[28](#CIT0028)\] to investigate the role of the BMAL1 and CLOCK proteins in cell cycle progression. We show that cell cycle duration is prolonged after siRNA mediated silencing of either *Bmal1* or *Clock* expression, and provide insight into the mechanism underlying this effect. Moreover, we used the biological data to probe and reinforce the computational model for the coupled mammalian circadian clock and cell cycle oscillators.

Results {#S0002}
=======

Suppression of *Bmal1* expression lengthens the cell cycle {#S0002-S2001}
----------------------------------------------------------

To study the role of BMAL1 in cell cycle progression, we used NIH3T3^3C^ cells, expressing fluorescent markers for the circadian clock (Rev-Erbα-VNP fusion protein; yellow), as well as G1 phase (hCdt1-mKOrange fusion protein; red) and combined S, G2, and M (hereafter referred to as S/G2/M) phase (hGeminin-CFP fusion protein; blue) of the cell cycle \[[28](#CIT0028)\]. NIH3T3^3C^ cells were transiently transfected with a siRNA targeting *Bmal1* mRNA or with a non-targeting siRNA (used as a negative control) and are hereafter referred to as *siBmal1* and *siCtrl* cells, respectively. Analysis of *Bmal1* mRNA and BMAL1 protein levels in proliferating *siBmal1* cells 72 hours after transfection, revealed 74% down regulation of *Bmal1* gene expression in *siBmal1* cell cultures (Fig EV1A), resulting in a 71% reduction in BMAL1 protein (Fig EV1B) levels.

We first analysed clock performance and cell cycle progression in *siBmal1* and *siCtrl* cells (n = 50 individual cells per condition) over a period of 72 hours using live cell imaging confocal microscopy (see [Figure 1(a](#F0001)) for a representative example of time lapse images of a *siCtrl* cell, spanning a complete G1/S/G2/M cycle). In line with our previous data \[[28](#CIT0028)\], proliferating *siCtrl* cells show robust rhythmic expression of the clock marker and a tight phase coupling of the circadian clock and cell cycle ([Figure 1(b](#F0001))). The period of the cell cycle, as calculated from the interval between two peaks of hCdt1-mKOrange expression, is 17.1 ± 0.3 h (mean ± SE; [Figure 1(c](#F0001))). In marked contrast, we observed a complete suppression of circadian oscillations and robust down regulation of Rev-Erbα-VNP protein levels in proliferating *siBmal1* cells, indicative for efficient knockdown of *Bmal1* expression ([Figure 1(b](#F0001))). Moreover, knockdown of *Bmal1* expression significantly (p \< 0.001) increased cell cycle length from 17.1 ± 0.3 h to 21.4 ± 0.5 h (mean ± SE; [Figure 1(c](#F0001))).10.1080/15384101.2018.1558638-F0001Figure 1.Cell cycle dynamics in *siCtrl* and *siBmal1* cells. (a) Representative example of time series images of the nucleus of a proliferating *siCtrl* (NIH3T3^3C^) cell, stably expressing circadian clock (Rev-Erbα-VNP; yellow), as well as G1 (hCdt1-mKOrange; red) and S/G2/M (hGeminin-CFP; blue) cell cycle markers. Shown are pictures at 1.5 hour time intervals over a 18 h period, spanning one cell cycle. (b) Circadian clock performance and cell cycle progression in a *siCtrl* (left panel) and a *siBmal1* cell (right panel). Plotted are fluorescence intensities of each of the markers over a 48 hour period. The G1 phase is defined as the interval between the peaks of hGeminin-CFP and hCDT1-mKOrange expression. Oppositely, the S/G2/M phase is defined as the interval between the peaks of hCDT1-mKOrange and hGeminin-CFP expression. (c) Box plot showing the cell cycle period and G1 and S/G2/M cell cycle phase length in *siCtrl* and *siBmal1* cells (n = 50 cells per condition). Lowest and highest boundaries of the box indicate the 25^th^ and 75^th^ percentiles, respectively. The whiskers above and below the box designate the 95^th^ and 5^th^ percentiles, respectively. The solid line and cross within the box represent the median and mean value, respectively. \*\*\* p \< 0.001 (Mann Whitney U test).

Next, we quantified the length of G1 and S/G2/M phase in *siCtrl* and *siBmal1* cells. For simplicity, as the FUCCI markers are indicators for either G1 or S/G2/M phase rather than exact predictors of the start and end of these cell cycle phases, we defined the G1 phase as the interval between the peaks of hGeminin-CFP and hCDT1-mKOrange expression, and the S/G2/M phase as the interval between the peaks of hCDT1-mKOrange and hGeminin-CFP expression. As shown in [Figure 1(c](#F0001)), the mean length of the G1 phase in *siCtrl* cells (8.2 ± 0.2 h) does not significantly differ (p = 0.2) from that in *siBmal1* cells (8.7 ± 0.3 h). Interestingly, the average length of the S/G2/M phase significantly (p \< 0.001) increased from 9.0 ± 0.8 h in *siCtrl* cells to 13.0 ± 0.3 h in *siBmal1* cells ([Figure 1(c](#F0001))).

Taken together, these results show that the BMAL1 protein acts as a cell cycle period modulator.

Suppression of *Bmal1* expression specifically affects the G2 phase {#S0002-S2002}
-------------------------------------------------------------------

The single-cell experiments show that silencing *Bmal1* expression lengthens the S/G2/M phase of the cell cycle, but do not allow to discriminate between the three phases. To investigate which specific cell cycle phase is prolonged, we compared the cell cycle distribution of proliferating *siCtrl* and *siBmal1* cells by flow cytometry of propidium iodide stained cells ([Figure 2(a](#F0002))) and quantified the cell cycle phase distribution ([Figure 2(b](#F0002))). In line with the single-cell experiments, we did not observe significant changes in the percentage of G1 and S phase cells after knockdown of *Bmal1* expression (G1 phase: 53.5 ± 1.2% and 52.7 ± 0.5%; S phase: 31.4 ± 1.0% and 28.5 ± 0.3 for *siCtrl* and *siBmal1* cells respectively; mean ± SEM). On the other hand, the percentage of G2/M cells significantly (p = 0.01) increased from 13.4 ± 0.5% in *siCtrl* cells to 17.1 ± 0.3% in *siBmal1* cells ([Figure 2(b](#F0002))). In order to discriminate between G2 and M phase, we also stained the cells with an antibody against the mitosis-specific MPM-2 phosphoepitope on DNA topoisomerase IIα. As shown in [Figure 2(c](#F0002)), the percentage of MPM2-positive cells is comparable for proliferating *siCtrl* and *siBmal1* cell cultures. From these data we conclude that the observed lengthening of the S/G2/M phase after knockdown of *Bmal1* is solely due to an increased duration of the G2 phase.10.1080/15384101.2018.1558638-F0002Figure 2.Cell cycle phase distribution of *siCtrl* and *siBmal1* cells. (a) Flow cytometric analysis of cell cycle phases in *siCtrl* and *siBmal1* cells. Shown are representative examples of propidium iodide (PI) stained *siCtrl* and *siBmal1* cells, analysed for DNA content (n = 3 experiments). The vertical axis indicates the relative number of cells and the horizontal axis indicates the relative PI fluorescence. The 2N and 4N peaks and intermediate region correspond to G1, G2/M and S phase, respectively. (b) Quantification of cell cycle phase distribution of proliferating *siCtrl* and *siBmal1* cells. Shown are the average cell numbers of the 3 independent experiments (each performed in triplicate; 20,000 cell counts per triplicate). The data were compared using the two-tailed unpaired Student's t-test. Error bars indicate SE. \*\* p \< 0.01. (c) Flow cytometry analysis of the number of mitotic cells. The bivariate dot plots show DNA content (PI) and mitotic phosphoproteins content (MPM2 stain) on the X and Y axis, respectively. The box marks cells stained positive for MPM2. (d) Western blot analysis of whole cell extracts from proliferating *siCtrl* and *siBmal1* cells for Cyclin D1, Cyclin E, Cyclin A, and Cyclin B1 proteins. Shown are representative examples of n = 3 independent experiments. Actin was used as a loading control. (e) Average cyclin protein levels in proliferating *siCtrl* and *siBmal1* cells (n = 3 independent experiments). Cyclin expression levels were normalized against actin. Cyclin expression levels in control cells were set as 1. Error bars indicate SD (n = 3 experiments).

Suppression of *Bmal1* expression specifically affects Cyclin B1 expression {#S0002-S2003}
---------------------------------------------------------------------------

The observed lengthening of the combined S/G2/M phase in *siBmal1* cells (single-cell analysis) and increased number of *siBmal1* cells in the G2 phase (flow-cytometry analysis) clearly point to a regulatory role of BMAL1 in the kinetics of the cell cycle. We therefore next examined the expression levels of the various cyclins in proliferating *siCtrl* and *siBmal1* cells by western blot analysis ([Figure 2(d](#F0002))). Following quantification ([Figure 2(e](#F0002))), the expression levels of Cyclin D1, Cyclin E, and Cyclin A (important regulators of G1 phase, G1/S transition and S phase, respectively) in *siBmal1* cells did not significantly differ from those in *siCtrl* cells. However, the Cyclin B1 (a driver of G2/M transition) protein level is significantly (p = 0.03) reduced in *siBmal1* cells. This suggests that the accumulation of *siBmal1* cells in G2 phase, and the delay in G2/M transition, are caused by low levels of Cyclin B1.

Suppression of *Bmal1* expression causes an overall reduction of Cyclin B1 expression {#S0002-S2004}
-------------------------------------------------------------------------------------

Obviously, aforementioned experiments with asynchronously proliferating cells do not discriminate between the various cell cycle phases. We therefore set out to further investigate the expression and kinetics of accumulation of the various cyclins in cell cycle synchronized *siCtrl* and *siBmal1* cells. To this end, we used a single 24 hour thymidine block, which causes cells to accumulate at G1/S boundary. As shown by flow cytometry, after release from the thymidine block *siCtrl* and *siBmal1* cells proceed through S phase and enter G2 phase with comparable kinetics (Fig EV2). Moreover, pulse-labeling of *siCtrl* and *siBmal1* cells with 5-ethynyl-2′-deoxyuridine (EdU) for one hour at 1 h intervals after release from the thymidine block ([Figure 3(a)](#F0003)) revealed that DNA synthesis (as detected by immunofluorescent labeling) in *siCtrl* and *siBmal1* cells follows similar kinetics, peaking 3 hours after thymidine block release ([Figure 3(b)](#F0003)). Assuming that the peak in DNA synthesis represents mid-S phase, S phase in *siCtrl* and *siBmal1* cells is estimated to span 5 to 6 hours, which is in good agreement with the flow cytometry data (30% S-phase cells at a cell cycle length of 18 hours = 5.4 h). Next, we determined Cyclin E (G1/S marker) and Cyclin A2 (S phase marker) protein levels by western blot analysis in *siCtrl* and *siBmal1* cells harvested 0, 2, 4, 6, 8, and 10 hours after release from thymidine ([Figure 3(c)](#F0003)). Quantification of the cyclin levels ([Figure 3(d,e)](#F0003)) revealed that kinetics of Cyclin E and Cyclin A2 were comparable to *siCtrl* cells, which is in complete agreement with our observation that *siBmal1* cells show normal G1 and S phase progression.10.1080/15384101.2018.1558638-F0003Figure 3.Cell cycle protein expression in *siCtrl* and *siBmal1* cells. (a) Cytochemical analysis of DNA synthesis in cell cycle synchronized *siCtrl* and *siBmal1* cells after release from a 24 h thymidine block. Cells were harvested at 1 h intervals. Prior to harvesting, cells were exposed to a 1 h pulse labelling with EdU. (b) S phase kinetics. Quantification of Edu incorporation by *siCtrl* and *Bmal1* cells during the 1 h pulse labelling interval, preceding cell harvesting. The Y axis indicates the mean fluorescence intensity, corrected for the number of cells. The X axis indicates time of harvesting after thymidine release. Error bars indicate SD (n = 3 experiments). The grey bar indicates the estimated time of S/G2 transition. (c, f and h) Western blot analysis of Cyclin E and Cyclin A2 (c), Cyclin B1 (f) and WEE1 (h) protein levels in *siCtrl* and *siBmal1* cells after release from a thymidine block. Shown are representative examples of n = 3 independent experiments. Actin was used as a loading control. (d,e,g and i) Kinetics of Cyclin E (d), Cyclin A2 (e), Cyclin B1 (g) and WEE1 (i) expression after release from a thymidine block. Expression levels were normalized against actin. Expression levels in *siCtrl* cells at t = 0 were set as 1. Error bars indicate SD. The grey bar indicates the estimated time of S/G2 transition.

Next, we determined Cyclin B1 protein levels in *siCtrl* and *siBmal1* cells after release from the thymidine block. As shown in [Figure 3(f,g)](#F0003), *Cyclin* B1 protein levels gradually increased in *siCtrl* cells, reaching a maximum 6 h after thymidine release at the moment when cells are in G2 phase. In line with our earlier observation in asynchronously dividing cells ([Figure 2(d,f)](#F0002)), *siBmal1* cells express the Cyclin B1 protein at lower levels. Moreover, *siBmal1* cells display impaired induction of Cyclin B1 during G2 phase, which may explain the delay in G2/M transition.

Last but not least, as WEE1 is an inhibitor of Cyclin B/CDK1 activity and *Wee1* expression is under circadian control \[[22](#CIT0022)\], we also analyzed aforementioned protein samples for WEE1 expression ([Figure 3(h)](#F0003)). As expected, in the absence of the CLOCK/BMAL1 transcription activator, *siBmal1* cells express WEE1 protein at markedly reduced level ([Figure 3(i)](#F0003)). However, as reduced expression of this negative regulator is expected to accelerate, rather than delay G2 to M transition, the lower WEE1 protein levels in *siBmal1* cells do not explain the delayed G2/M transition. Instead, our data demonstrate that the circadian clock protein BMAL1 is a modulator of cell cycle period that promotes G2 to M transition through induction of Cyclin B1 expression.

Suppression of *Clock* expression lengthens the cell cycle and dampens Cyclin B1 expression {#S0002-S2005}
-------------------------------------------------------------------------------------------

The question arises to what extent the observed modulation of G2/M transition is a specific function of the individual BMAL1 protein, or whether this requires CLOCK/BMAL1 heterodimerization. We therefore transiently transfected NIH3T3^3c^ cells with a siRNA targeting the *Clock* gene or with a non-targeting control siRNA to obtain *siClock* cells. Analysis of *Clock* mRNA and CLOCK protein levels in proliferating *siClock* and *siCtrl* cells 72 hours after transfection, revealed 63% down regulation of *Clock* gene expression in *siClock* cell cultures (Fig EV1C), resulting in a 88% reduction in CLOCK protein levels (Fig EV1D. We next analysed clock performance and cell cycle progression in *siClock* and *siCtrl* cells (n = 40 individual cells per condition) over a period of 72 hours using time-lapse confocal microscopy (for a representative example, see [Figure 4(a](#F0004))). Like *siBmal1* cells, *siClock* cells are arrhythmic, as evident from the loss of cyclic expression of the REV-ERBα clock reporter, and proliferate significantly slower (p = 0.03) than *siCtrl* cells (19.7 ± 0.3 h vs 18.7 ± 0.3 h per cycle; mean ± SEM). As shown in [Figure 4(b](#F0004)), the G1 phase was not significantly affected in *Clock* knock down cells, as compared to *siCtrl* cells (9.2 ± 0.2 h vs 8.5 ± 0.3 h; mean ± SEM p = 0.07). Instead, the increased cell cycle period in *siClock* cells originates from a lengthened S/G2/M phase (9.4 ± 0.1 h in *siCtrl* and 11.0 ± 0.2 h in *siClock* cells; p \< 0.001). Subsequent analysis of the cell cycle distribution of proliferating *siCtrl* and *siClock* cells by flow cytometry revealed a significant increase in the percentage of G2/M cells (14.3 ± 0.1 in *siCtrl* and 20.1 ± 1.2 in *siClock* cells; mean ± SEM; p = 0.03), and relatively less S phase cells in proliferating *siClock* cell cultures (27.1 ± 0.6 in *siCtrl* and 21.3 ± 1.0 in *siClock* cells; p = 0.01) ([Figure4(d](#F0004))). These findings indicate that proliferating *siClock* cells markedly resemble *siBmal1* cells in that the cell cycle period is increased due to slower G2/M cell cycle progression.10.1080/15384101.2018.1558638-F0004Figure 4.Cell cycle dynamics and Cyclin B1 protein expression in *siCtrl* and *siClock* cells. (a) Circadian clock performance and cell cycle progression in a *siCtrl* (left panel) and a *siClock* cell (right panel). Plotted are fluorescence intensities of each of the markers over a 60 hour period. (b) Box plot showing the cell cycle period and G1 and S/G2/M cell cycle phase length in *siCtrl* and *siClock* cells (n = 40 cells per condition). Lowest and highest boundaries of the box indicate the 25^th^ and 75^th^ percentiles, respectively. The whiskers above and below the box designate the 95^th^ and 5^th^ percentiles, respectively. The solid line and cross within the box represent the median and mean value, respectively. \* p \< 0.05; \*\*\* p \< 0.001 (Mann Whitney U test). (c) Flow cytometric analysis of cell cycle phases in *siCtrl* and *siClock* cells. Shown are representative examples of propidium iodide (PI) stained *siCtrl* and *siBmal1* cells, analysed for DNA content (n = 3 experiments). The vertical axis indicates the relative number of cells and the horizontal axis indicates the relative PI fluorescence. The 2N and 4N peaks and intermediate region correspond to G1, G2/M and S phase, respectively. (d) Quantification of cell cycle phase distribution of proliferating *siCtrl* and *siClock* cells. Shown are the average cell numbers of the 3 independent experiments (each performed in triplicate; 20,000 cell counts per triplicate). The data were compared using the two-tailed unpaired Student's t-test. Error bars indicate SE. \* p \< 0.05; \*\* p \< 0.01. (e) Western blot analysis of Cyclin B1 protein levels in *siCtrl* and *siClock* cells after release from a thymidine block. Shown are representative examples of n = 3 independent experiments. Actin was used as a loading control. (f) Kinetics of Cyclin B1 expression after release from a thymidine block. Cyclin B1 expression levels were normalized against actin. The Cyclin B expression level in *siCtrl* cells at t = 0 was set as 1. Error bars indicate SD (n = 3 experiments).

We therefore next analyzed the kinetics of Cyclin B1 accumulation in *siClock* and *siCtrl* cells after release from a 24 hour thymidine block ([Figure 4(d](#F0004))). As expected, Cyclin B1 protein levels gradually increased in *siCtrl* cells peaking 6 hours after thymidine release ([Figure 4(e](#F0004)), see also [Figure 3(g](#F0003))). In contrast, *siClock* cells show markedly reduced Cyclin B1 protein levels peaking between 6 and 8 hours after thymidine release ([Figure 4(e](#F0004))). Taken together, these data indicate that modulation of G2/M transition through induction of Cyclin B1 is a characteristic of the CLOCK/BMAL1 heterodimer, rather than the BMAL1 protein alone.

Mathematical modeling of CLOCK/BMAL1-controlled cell cycle progression {#S0002-S2006}
----------------------------------------------------------------------

The biological data on the modulating effect of CLOCK/BMAL1 on cell cycle progression serve as an ideal tool to probe and reinforce the computational model for coupled mammalian circadian clock and cell cycle oscillators, as defined by Goldbeter and coworkers \[[6](#CIT0006),[29](#CIT0029),[30](#CIT0030),[32](#CIT0032)\]. We therefore set out to test whether the computational model would also respond with a delay in G2/M transition after simulating a reduction in *Bmal1* or *Clock* expression levels. The coupling between the circadian clock and the cell cycle is mediated by several cell cycle proteins such as WEE1 \[[22](#CIT0022)\], p21 \[[23](#CIT0023)\], NONO \[[24](#CIT0024)\], and, as shown here, Cyclin B1. Oppositely, there are indications that the cell cycle may have an effect on the circadian clock, but the mechanism of such a coupling remains unclear \[[33](#CIT0033),[34](#CIT0034)\], although a recent study points to the enhancement of REV-ERBα degradation through phosphorylation by CDK1 \[[25](#CIT0025)\]. Therefore, despite recent evidence for bidirectional coupling between the cell cycle and the circadian clock \[[27](#CIT0027),[28](#CIT0028)\], we decided to focus on the situation where the cell cycle is unidirectionally coupled to the circadian clock via CLOCK/BMAL1-mediated induction of *Wee1* and *Cnnb1* expression. Below, we first model the impact of *Bmal1* inactivation on cell cycle progression, and subsequently address the effect of in silico knockdown of *Clock* gene expression.

We consider that in proliferating cells the circadian clock has an overall length of 18 hours (close to the value of 17.1 h observed experimentally in proliferating *siCtrl* cells; [Figures 1(b,c)](#F0001). We select an autonomous period of the cell cycle of 21.1 h, which is close to the cell cycle length observed in *siBmal1* cells in the absence of the circadian clock ([Figure 1(b)](#F0001)). In line with the experimental data ([Figure 1(b)](#F0001)), the time evolution of *Bmal1* and *Rev-Erbα* mRNA levels in our computational model shows that under control conditions the circadian clock oscillates with a cycle length of 18h ([Figure 5(a)](#F0005)), while all four Cyclin/CDK protein complexes ([Figure 5(c)](#F0005)), as well as the WEE1 protein ([Figure 5(e)](#F0005)) display sustained oscillations with the same period. These results represent entrainment of the cell cycle by the circadian clock via BMAL1-mediated induction of *Wee1* and *CcnB1 (Cyclin B1)* gene expression. This circadian control comes on top of a basal expression of the two genes, as suggested by the observation of low levels of Cyclin B1 and WEE1 protein in *siBmal1* cells ([Figures 3(g,i)](#F0003)).10.1080/15384101.2018.1558638-F0005Figure 5.Computational modeling of the impact of *Bmal1* knockdown on Cyclin/CDK levels. Analysis of the effect of silencing of *Bmal1* expression in the computational model for coupled mammalian circadian clock and cell cycle oscillators. The time series in the upper panels show the evolutions of *Bmal1* mRNA (dark cyan, solid line), total BMAL1 protein (dark cyan, dashed line) and *Rev-Erbα* mRNA (orange) under normal conditions (a) or when the synthesis rate of *Bmal1* mRNA is reduced by 70% (b). The period of the circadian clock is 18h in control conditions. However, the oscillations in (b) disappear upon decreasing *Bmal1* mRNA synthesis. The time series in the middle panels show the time evolutions of Cyclin A/CDK2 (light green), Cyclin E/CDK2 (mustard green), Cyclin B/CDK1 (blue) and CyclinD/CDK4-6 (red) in control conditions, when the cell cycle is synchronized to the circadian clock (c), or when *Bmal1* is knocked down (d). The period of the cell cycle increases from 18h in (c) to 21.1 h in (d). Also, the width of the activity peak of Cyclin B/CDK1 (blue) is significantly increased. The time series in the bottom panels show the evolutions of Cyclin B/CDK1 (blue) and WEE1 (black) when cells are in control conditions (c) or when *Bmal1* gene expression is knocked down (d). The concentration of WEE1 decreases in (d) due to the lack of induction *Wee1* transcription by BMAL1. Parameter values used for numerical simulations are listed in the SI appendix.

When *Bmal1* gene expression is suppressed in silico by reducing the *Bmal1* mRNA synthesis rate (*v~sB~*) by 70%, computational time series analysis reveals that *Bmal1* mRNA levels are no longer oscillating and that BMAL1 protein levels are constitutively low ([Figure 5(b)](#F0005)). As a consequence, *Rev-Erbα* mRNA levels are also constitutively low ([Figure 5(b)](#F0005)). These data are in full agreement with the experimental data obtained with *siBmal1* cells ([Figure 1(b)](#F0001); Figs EV1A and EV1B) and show that the circadian clock is arrested when *Bmal1* expression is knocked down. Interestingly, and also in full agreement with the experimental data, the cell cycle length is prolonged from 18h to 21.1 h after in silico reduction of *Bmal1* expression levels (compare [Figures 5(c,d)](#F0005)). Notably, the width of the activity peak of Cyclin B/CDK1 is significantly increased upon suppression of *Bmal1* expression, while that of other Cyclins appears unaffected ([Figures 5(c,d)](#F0005)). In addition, the WEE1 protein concentration decreases in the model after in silico *Bmal1* knockdown due to the lack of CLOCK/BMAL1-mediated induction of *Wee1* gene expression ([Figures 5(e,f)](#F0005)).

Next, we examined in more detail how suppression of *Bmal1* expression in our mathematical model affects the duration of the G1 and S/G2/M cell cycle phases. To this end, we defined the G1 phase as the time from mid-decrease of Cyclin B/CDK1 to 30%-decrease of Cyclin D/CDK4-6 levels and the S/G2/M phase as the time from 30%-decrease of Cyclin D/CDK4-6 to mid-decrease of Cyclin B/CDK1 levels (see [Figure 6(a,b)](#F0006)). Analysis of the computed time series reveals that under normal conditions, the G1 and S/G2/M phases span 5.84 h and 12.19h, respectively ([Figure 6(a)](#F0006)), while in silico reduction of *Bmal1* mRNA synthesis by 70% results in G1 and S/G2/M cell cycle phase lengths of 6.41 h and 14.74 h, respectively ([Figure 6(b)](#F0006)). Thus, in line with the experimental data ([Figures 1(b,c)](#F0001)), elongation of the cell cycle period upon suppression of *Bmal1* expression is predominantly caused by lengthening of the S/G2/M phase.10.1080/15384101.2018.1558638-F0006Figure 6.Computational modeling of the impact of *Bmal1* knockdown on cell cycle phase length. The time series in the upper panels show the evolutions of Cylin D/CDK4-6 (red) and Cyclin B/CDK1 (blue) when the circadian clock is in control conditions (a) or when *Bmal1* expression is reduced by 70% (b). As in the corresponding [Figure 4](#F0004), the period of the cell cycle increases from 18 h in (a) up to 21.1 h when *Bmal1* expression is supressed (b). The black bars indicate the G1 phase (from mid-decrease of Cyclin B/CDK1 to 30%-decrease in Cyclin D/CDK4-6) and S/G2/M phase (from 30%-decrease in Cyclin D/CDK4-6 to mid-decrease of cyclin B/CDK1). The durations of G1 and S/G2/M in (a) are 5.84 h and 12.19 h, respectively. The durations of G1 and S/G2/M in (b) are 6.41 h and 14.74 h, respectively. Thus, the S/G2/M phase contributes most to the prolongation of cell cycle duration upon knocking down BMAL1. The time series in the lower panels show the evolutions of total Cyclin B (dashed blue line) in control conditions (c) or upon suppression of *Bmal1* RNA synthesis (d). The total amount of Cyclin B (free + complexed with the kinase CDK1 and its inhibitor p21) decreases when *Bmal1* expression is reduced.

The mathematical simulations, as shown above, reveal a normal amplitude oscillation of Cyclin B/CDK1 levels after 70% reduction of the *Bmal1* mRNA synthesis, which appears to contrast somewhat with the experimental data, showing a 20--25% reduction in Cyclin B1 protein levels. We therefore also determined the time evolution of the total Cyclin B1 protein level (free and complexed with CDK1) under control conditions ([Figure 6(c](#F0006))) and upon reduced *Bmal1* gene expression ([Figure 6(d](#F0006))). The results indicate that, as in the experimental observations (see [Figure 2(d](#F0002))), total Cyclin B1 levels decrease upon knocking down *Bmal1*, which holds with the view that BMAL1 induces *CcnB1* gene expression, as reported above.

Similar results were obtained upon knocking down *Clock* instead of *Bmal1* in the computational model for coupled mammalian circadian clock and cell cycle oscillators (data not shown), which may not come as a surprise as CLOCK and BMAL1 act as a heterodimeric complex.

In conclusion, the performance of the computational model for coupled mammalian circadian clock and cell cycle oscillators after simulation of *Bmal1* or *Clock* silencing is in full agreement with the experimental observations in proliferating *siCtrl, siBmal1* and *siClock* cells.

Discussion {#S0002-S2007}
----------

Previously, we have reported the existence of a bi-directional link between the circadian clock and the cell cycle \[[28](#CIT0028)\]. Indeed, synchronization and resetting of the circadian clock by external cues (such as dexamethasone) can synchronize cell cycle progression. Oppositely, a clear shortening of the circadian cycle occurred in dividing cells as compared to non-dividing cells, suggesting that the cell cycle can reset the circadian clock. In the present study, we have taken a combined cell and molecular biological approach to investigate the impact of the circadian clock on cell cycle progression by genetic disruption of the molecular circadian oscillator. We show that disruption of the positive limb of the circadian transcription-translation feedback loop-based molecular oscillator through knock-down of the circadian clock genes *Bmal1* or *Clock* prolonged the cell cycle of cultured fibroblasts. Our results show that this slowdown in cell cycle progression results from a delay in the G2/M transition. Since inactivation of *Bmal1* or *Clock* triggers a highly comparable cell cycle phenotype, G2/M checkpoint control appears a function of the CLOCK/BMAL1 heterodimer, rather than the individual proteins.

To investigate the molecular mechanism underlying the observed delay in cell cycle progression in the absence of BMAL1 or CLOCK, we zoomed in on cell cycle protein expression during G2 phase and G2/M transition using cell cycle synchronized *siBmal1* and *siClock* cells. Interestingly, whereas the kinetics of S phase progression remained unaffected, knockdown of *Bmal1* or *Clock* expression resulted in overall lower Cyclin B1 protein levels, as well as a reduction of the Cyclin B1 peak at G2 phase. Since a high Cyclin B1 protein level is essential for G2 progression and mitotic entry, the impaired induction of Cyclin B1 protein levels well explains the delayed cell cycle progression in G2 phase. This view is consistent with the study by Matsuo and coworkers \[[22](#CIT0022)\] focussing on cell cycle re-entry of remaining mouse hepatocytes after partial hepatectomy at ZT0 or ZT8 (ZT, Zeitgeber time in a 12 hour light--12 hour dark cycle; ZT0 represents lights on and ZT12, lights off). Whereas S phase kinetics was independent of the time of surgery, *CcnB1* mRNA and Cyclin B1 protein levels, as well as Cyclin B1/CDK1 peak activity, were delayed by about 8 to 12 hours when partial hepatectomy was performed at ZT0 as compared to ZT8 \[[22](#CIT0022)\], demonstrating that clock-controlled timing of Cyclin B1 expression and activity is determining G2/M transition.

It has been well established that expression of the *Wee1* gene, encoding an important kinase regulating the G2/M checkpoint, is under direct control of the CLOCK/BMAL1 complex \[[22](#CIT0022)\]. As WEE1 acts as an inhibitor of CDK1 to prevent premature mitotic entry, one would expect inhibition of *Bmal1* expression to accelerate cell cycle progression due to a reduction of WEE1 protein level and kinase activity. On the contrary, however, we observed a delay in G2/M transition of proliferating *siBmal1* and *siClock* cells, accompanied by a reduction in Cyclin B1 protein levels. It appears, therefore, that the CLOCK/BMAL1 complex regulates at the same time the expression of an inhibitor (WEE1) and an activator (Cyclin B1) of G2/M transition. Regardless of this dual role of the CLOCK/BMAL1 complex in controlling the G2/M checkpoint, the increased cell cycle length of *siBmal1* and *siClock* cells suggests that the dominant effect of CLOCK/BMAL1 is to induce expression of the Cyclin B1 encoding gene *Cnnb1*. The induction of *Wee1* by CLOCK/BMAL1 could nevertheless contribute to further extending the duration of the G2/M phase by enlarging the width of the peak in CyclinB1/CDK1 in the absence of its inhibitor WEE1 in *siBmal1* cells. Such a counter-intuitive effect is suggested by numerical simulations of the mathemathical model for coupled clock -- cell cycle oscillators, which showed that induction of *Wee1* by CLOCK/BMAL1 can shorten the duration of the cell cycle by reducing the half-width of the peaks in Cyclin B1/CDK1 \[[32](#CIT0032)\].

Understanding how transcription of the Cyclin B1 gene *CcnB1* is regulated during the cell cycle would help us to understand how BMAL1 can modulate cell cycle progression. Promoter analysis of the human *CcnB1* gene uncovered four E-box elements (CANNTG), one of which showing consensus for the Upstream Stimulatory Factor (USF) and acting as a G2-specific regulator of *Cyclin B1* expression \[[35](#CIT0035)\]. Since the USF E-box sequence CACGTG matches that of the E-box elements recognized by CLOCK/BMAL1, this results suggest a direct role for BMAL1 in the G2-specific induction of *CyclinB1*. However, the USF element in the mouse promoter has a different sequence and no longer matches the E-box sequence \[[36](#CIT0036)\]. We therefore conclude that the effect of BMAL1 on Cyclin B1 levels must be indirect through (cyclic) expression of other clock genes or clock-controlled genes. A good candidate is P300, which was shown to regulate transcription of Cyclin B1 \[[36](#CIT0036)\]. Furthermore, inhibition of P300 was shown to induce cell cycle arrest \[[37](#CIT0037),[38](#CIT0038)\]. We analysed expression of p300 in siCtrl and siBmal1, and found that p300 is downregulated upon *Bmal1* knockdown (Fig. EV3). This suggests that the decreased Cyclin B1 levels in siBmal1 are a result of lower levels of p300 induced transcription of Cyclin B1.

BMAL1 has been shown to control expression of the tumor suppressor gene p53 \[[39](#CIT0039),[40](#CIT0040)\]. The p53 protein, in turn, has been suggested to prevent G2/M transition by attenuating *CcnB1* promoter activity and reducing Cyclin B1 protein levels \[[41](#CIT0041)\]. Adding to the level of complexity of circadian control of G2/M transition, the circadian clock protein PER2 (expression of which is under control of CLOCK/BMAL1) can stabilize the p53 protein and influence its subcellular localization, i.e. cytoplasmic vs nuclear \[[42](#CIT0042)\].

The availability of a model for the coupling of the cell cycle to the circadian clock in mammalian cells allows us to probe, by means of computer simulations, the effect of knocking down *Bmal1* or *Clock* on the dynamics of the cell cycle. Previous theoretical investigations of this coupling \[[32](#CIT0032)\] were based on the circadian control of several components of the cell cycle machinery, such as the kinase WEE1, the CDK inhibitor p21, and Cyclin E. Here, the experimental study confirmed that WEE1, a kinase that inhibits CDK1, is under control of the circadian clock via the induction of *Wee1* expression by CLOCK/BMAL1. The experiments uncovered an additional mode of coupling due to the induction of *CcnB1* expression by CLOCK/BMAL1. We therefore incorporated these two modes of coupling into the combined model for the cell cycle and circadian clock in mammalian cells.

The model indicates that the induction of *Ccnb1* and *Wee1* expression by CLOCK/BMAL1 allows the cell cycle to synchronize with to the circadian clock at a period in the order of 18h. Upon suppression of BMAL1 expression by reducing the *Bmal1* mRNA synthesis rate by 70%, the circadian clock stops ticking and the cell cycle recovers its autonomous period of oscillation, close to 21h. The lengthening of the period in our mathematical model is largely due to an increase of a few hours in the duration of the S/G2/M phase, which is in good agreement with the experimental data. The simulations suggest that this increase can be related to an increase in the half-width of the peak in CDK1. The larger duration of the peak in CDK1 is due to the decreased inhibition of the enzymatic activity by WEE1, given that the level of this inhibitory kinase drops when knocking down its inducer BMAL1. In this respect it is interesting to note that inactivation of BMAL1 in hippocampal neurons both experimentally and in silico causes a cell cycle effect, i.e. delayed cell cycle exit \[[43](#CIT0043)\].

Disruption of the circadian clock (genetically or environmentally) results in altered cell proliferation, and in some cases cancer predisposition. However, only few studies have been performed to detect the intracellular pathways or the key molecules responsible for the altered proliferation capacity. Our study addressed the role of BMAL1 and CLOCK in the expression of Cyclin B1, one of the key molecules for G2 phase and G2/M transition. The question arises whether the reduced Cyclin B1 protein levels in the absence of CLOCK/BMAL1 are the result of (i) the inactivation of the positive limb of the circadian transcription translation feedback loop, or (ii) a complete/overall loss of the clock. Future experiments with circadian clock deficient *Cry1/Cry2* knockdown NIH3T3^3C^ cells should provide an answer to this question.

Finally, stable gene silencing of Cyclin B1 has been reported to inhibit proliferation, and sensitizes breast cancer cells to taxol treatment \[[44](#CIT0044)\]. Downregulation of Cyclin B1 via knock-down of *Bmal1* could be an attractive strategy for anti-proliferative therapy. This might ultimately delay tumor progression. However, the state of circadian clock and cell cycle coupling in cancer cells still remains to be studied.

Materials & methods {#S0003}
===================

Cell culture and gene knockdown {#S0003-S2001}
-------------------------------

NIH3T3 and NIH3T3^3c^ cells, the latter containing *Rev-Erbα-VNP* clock reporter and FUCCI *hCdt1-mKOrange* and *hGeminin-CFP* FUCCI cell cycle reporter genes \[[28](#CIT0028)\] were cultured in Dulbecco's Modified Eagle's Medium (DMEM)/F10 (Lonza) containing 10% Fetal Bovine Serum (FBS) (Gibco), 100 U/ml Penicillin and 100 µg/ml Streptomycin in a standard humidified incubator at 37°C and 5% CO~2~ (pH7.7).

To knockdown *Bmal1* or *Clock* expression, we used Silencer® Select Pre-designed siRNA for *Arntl* (ThermoFisher Scientific; catalog number 4390771) and Clock (ThermoFisher Scientific; catalog number 4390771). As a negative control, we used Silencer® Select Negative Control No. 1 siRNA (ThermoFisher Scientific; catalog number 4390843). Reverse transfection was performed in 6 well plates (population studies) or in 4 well poly-L-lysine coated glass bottom dishes (D141410, Matsunami Glass Ind.), using the Lipofectamine® RNAiMAX method (Invitrogen) as described by the manufacturer, except that Opti-MEM was replaced by (serum-free) DMEM/F10. After 24 hours, transfection medium was replaced by regular culture medium. Cells were harvested at the indicated time points and processed for further analysis.

In a subset of experiments, the cell cycle of proliferating cells was synchronized by treatment of cell cultures with 2.5 mM thymidine (Sigma), starting 48 hours after RNAi transfection. After 24 hours, cells were released from thymidine block by washing 3 times with PBS and harvested at the indicated time points.

Time-lapse fluorescence microscopy {#S0003-S2002}
----------------------------------

For time-lapse recording of circadian clock and cell cycle progression, cells (transfected and grown on glass bottom dishes) were placed in the temperature (37°C), CO~2~ (5%) and humidity controlled chamber of a live cell imaging Zeiss LSM510/Axiovert 200M confocal microscope, equipped with a 10x Ph objective. Images were recorded every 30 min for 72 hours or more using a Coolsnap HQ/Andor Neo sCMOS camera. Live cell imaging was conducted using the following parameters (as set up in Zeiss 200 software): Venus (green): 1000 ms (filter cube: Ex = 475/40 nm, DM = 500 nm, Em = 530/50 nm); mKO2 (red): 300 ms (filter cube: Ex = 534/20 nm, DM = 552 nm, Em: 572/38 nm); CFP (blue): 300 ms (filter cube: Ex = 458/17 nm, DM = 450 nm, Em: 479/40 nm). Acquired images were concatenated and merged into a single file to generate a movie which was used for further analysis as described in detail by Feillet and coworkers (Feillet et al., 2014). In short, single-cell numerical time series for each of the fluorescent markers were generated using the LineageTracker plugin for ImageJ (<https://github.com/pkrusche/lineagetracker.jsonexport>). Time series were analyzed for circadian cycle length, cell cycle length and G1 and S/G2/M cell cycle phase length. The G1 phase is defined as the interval between the peaks of hGeminin-CFP and hCDT1-mKOrange expression. Oppositely, the S/G2/M phase is defined as the interval between the peaks of hCDT1-mKOrange and hGeminin-CFP expression.

mRNA and protein analysis {#S0003-S2003}
-------------------------

Gene expression levels were determined by quantitative RT-PCR. Total RNA was isolated from cultured cells in triplicate using TRIzol (Invitrogen) following manufacturer's instructions. First-strand cDNA was synthesized from 1 μg of total RNA using oligo (dT) primers and SuperScript reverse transcriptase (Invitrogen) according to the manufacturer's protocol. Quantitative PCR amplification was performed using the iCycler iQ™ Real-Time PCR Detection System (BioRad), with SYBR-green and primer sets generating intron-spanning products of 150--300 bp. The following forward and reverse primers were used: *Bmal1*: Fwd 5ʹ-AAG CTT CTG CAC AAT CCA CAG CAC-3ʹ and Rev 5ʹ-TGT CTG GCT CAT TGT CTT CGT CCA-3ʹ; *Clock*: Fwd 5ʹ-CTT CCT GGT AAC GCG AGA AAG −3ʹ and Rev 5ʹ-GTC GAA TCT CAC TAG CAT CTG AC −3ʹ; *B2M*: Fwd 5ʹ-CCG GCC TGT ATC CAG AAA-3ʹ and Rev 5ʹ-AAT TCA ATG TGA GGC GGG TGG AAC-3ʹ.

Protein expression levels were determined by Western blot analysis. Cells were lysed in RIPA lysis buffer, composed of 2 mM Tris-HCl PH8.0, 1% TX-100, 0.5% NaDOC, 0.1% SDS, 5.15 mM NaCl, 5 mM NaF, 1.25 mM NaVO~3~, 10 mM EDTA supplemented with a PhosSTOP phosphatase inhibitor tablet (Roche) and a Pierce Protease Inhibitor tablet (ThermoFisher). Lysates were cleared by centrifugation at 13,000 g for 10 minutes at 4°C. Protein concentration was determined using the BCA Protein Assay Reagent (Pierce®, Thermo Scientific). Absorbance was measured at 560 nm using a GloMax-Multi+ Microplate Multimode Reader (Promega). Proteins were loaded on Bis-Tris Plus 4--12% polyacrylamide gel (Novex®, Life technologies), size separated and transferred to a Polyvinylidene fluoride (PVDF) membrane. After blocking with 4% skim milk, membranes were incubated with a primary antibodies (listed below) overnight at 4°C. After washing, membranes were incubated with the secondary antibodies (1:2000 dilution) for 1 hour at 4°C. Protein bands were visualized using Western Lightning™ Chemiluminescence Reagent Plus (PerkinElmer) and autoradiography. Bands were quantified by Fiji® software and normalized against to β-actin protein levels.

Antibodies used: Primary antibodies: Actin C-2 (sc8432), BMAL1 (sc48790), CLOCK (sc25361), Cyclin B1 (sc245), Cyclin A (sc751), and WEE1 (sc325) (all Santa Cruz), and Cyclin E (ab7959) and Cyclin D (ab134175), and (all Abcam). Secondary antibodies: goat anti-rabbit IgG (H + L)-HRP conjugate or goat anti-mouse IgG (H + L)-HRP conjugate.

Flow cytometry {#S0003-S2004}
--------------

To analyze cell cycle status by quantification of DNA content, cells were harvested 48 hours after siRNA transfection, washed with PBS, and fixed overnight at 4°C with cold 70% ethanol. Next, fixed cells were washed with PBS, treated for 15 min at 37°C with PBS containing 100 *μ*g/ml bovine pancreas RNase (Calbiochem), and left overnight at 4°C in PBS with 40 *μ*g/ml propidium iodide (PI; Life Technologies). Alternatively, to specifically detect mitotic cells, fixed cells were stained for the presence of the MPM-2 phospho-epitope on DNA topoisomerase IIα, using mouse anti-MPM2 primary antibodies (Merck-Millipore; dilution 1:200; 1 h on ice) and goat-anti mouse FITC secondary antibodies (Jackson ImmunoResearch; dilution 1:50; 30 min on ice). Cells were analyzed by a Becton Dickinson LSRFortessa^TM^ Cell Analyzer (BD Biosiences). PI and FITC fluorescence intensities were measured at 610 nm and 530 nm, respectively. For each condition, at least 20,000 cells were counted. Frequency histograms were made using BD FACSDiva^TM^ software (BD Biosciences).

DNA synthesis assay {#S0003-S2005}
-------------------

DNA synthesis was determined using the Click-iT® EdU Alexa Fluor® 594 Imaging Kit (Invitrogen). Cells were pulse labelled with 5-ethynyl-2ʹ-deoxyuridine (EdU) for 1 hour, fixed with 3.7% formaldehyde, and incubated with Alexa Fluor® 594 according to the manufacturer's instructions. Images were generated using a Zeiss Axiovert 200M microscope and processed using ImageJ software. For each image, total intensity was normalized to the number of cells.

Mathematical modeling {#S0003-S2006}
---------------------

To study the interaction between the circadian clock and the cell cycle we used two computational models previously proposed for the mammalian circadian clock and for the mammalian cell cycle, respectively. The model for the mammalian circadian clock incorporates the positive and negative regulations involving the PER, CRY, CLOCK, BMAL1 and REV-ERBα proteins \[[29](#CIT0029),[30](#CIT0030)\]. This model (in which, for simplicity, PER1 and PER2, as well as CRY1 and CRY2 are treated as single entities) accounts for the occurrence of spontaneous circadian oscillations of the above-mentioned proteins and their mRNAs in a variety of experimental conditions.

The model for the mammalian cell cycle is based on the regulatory properties of the CDK network that drives the transitions between the successive phases of the cell cycle \[[6](#CIT0006),[31](#CIT0031)\]. The model contains four CDK modules, each of which controls the transition to a particular cell cycle phase. Thus, Cyclin D/CDK4-6 and Cyclin E/CDK2 promote progression in G1 and elicit the G1/S transition; the activation of Cyclin A/CDK2 ensures progression in S and G2, while the peak of Cyclin B/CDK1 activity brings about progression into mitosis. Exit from the quiescent state is triggered above a critical level of growth factor by the synthesis of Cyclin D, which allows cells to enter the G1 phase. Synthesis of the various cyclins is regulated through the balance between the antagonistic effects exerted by the transcription factor E2F and the tumor suppressor pRB, which respectively promote and inhibit cell cycle progression. Additional regulations in this model for the CDK network bear on the control exerted by the proteins SKP2, CDH1, or CDC20 on the degradation of cyclins E, A, and B at the G1/S or G2/M transitions, respectively. Moreover, the activity of each cyclin/CDK complex can itself be regulated through CDK phosphorylation-dephosphorylation. At suprathreshold levels of growth factor sustained oscillations spontaneously occur in the CDK network, which may be associated with cellular proliferation since they correspond to the repetitive, sequential activation of the various cyclin-CDK complexes responsible for the ordered progression along the successive phases of the cell cycle \[[6](#CIT0006),[31](#CIT0031)\].

The cell cycle is coupled to the circadian clock through several molecular processes (see above), such as the induction of *Wee1* expression by CLOCK/BMAL1. Such coupling may lead to entrainment of the cell cycle by the circadian clock \[[32](#CIT0032)\]. The equations governing the models for the coupled circadian clock and cell cycle models are given in the Supporting Information section. Here we focus on the case where the cell cycle is coupled to the circadian control via the induction of *Wee1* gene expression by CLOCK/BMAL1. We also introduce coupling via the induction of *Cnnb1* (*Cyclin B1*) gene expression by CLOCK/BMAL1, as suggested by the experiments reported in the present study. To model the impact of knockdown of *Bmal1* gene expression, we reduce the rate of *Bmal1* mRNA synthesis (measured by parameter *v~sB~*) in the model for the circadian clock.

Statistical analysis {#S0003-S2007}
--------------------

All statistical analyses were carried out with GraphPad software. For single-cell studies, after performing the normality test, the two-tailed Mann-Whitney U-test was used to analyze the period of the circadian and cell cycle clocks (including G1, S/G2/M phase length). For Western blot, flow cytometry, and immunofluorescence experiments, the two-tailed Student's t-test was applied.
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